↓ Skip to main content

Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review

Overview of attention for article published in Journal of Pharmaceutical Policy and Practice, March 2019
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
2 X users

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
31 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Investigating the association of proton pump inhibitors with chronic kidney disease and its impact on clinical practice and future research: a review
Published in
Journal of Pharmaceutical Policy and Practice, March 2019
DOI 10.1186/s40545-019-0167-0
Pubmed ID
Authors

Ejaz Cheema

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 31 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 31 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 5 16%
Researcher 4 13%
Other 3 10%
Lecturer > Senior Lecturer 2 6%
Student > Postgraduate 2 6%
Other 6 19%
Unknown 9 29%
Readers by discipline Count As %
Medicine and Dentistry 10 32%
Pharmacology, Toxicology and Pharmaceutical Science 5 16%
Nursing and Health Professions 2 6%
Arts and Humanities 1 3%
Unspecified 1 3%
Other 2 6%
Unknown 10 32%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 04 July 2022.
All research outputs
#14,800,681
of 22,788,370 outputs
Outputs from Journal of Pharmaceutical Policy and Practice
#282
of 405 outputs
Outputs of similar age
#206,946
of 349,984 outputs
Outputs of similar age from Journal of Pharmaceutical Policy and Practice
#6
of 6 outputs
Altmetric has tracked 22,788,370 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 405 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 11.3. This one is in the 25th percentile – i.e., 25% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 349,984 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 37th percentile – i.e., 37% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 6 others from the same source and published within six weeks on either side of this one.